Pharmacokinetics (PK) and Pharmacodynamics (PD) Following Four Monthly Doses of a Human Monoclonal Anti-FGF23 (Fibroblast Growth Factor 23) Antibody (KRN23) in Adults with X-Linked Hypophosphatemia (XLH)
Publication
, Conference
Zhang, X; Imel, EA; Ruppe, MD; Weber, TJ; Klausner, M; Ito, T; Vergeire, M; Humphrey, J; Glorieux, FH; Portale, AA; Insogna, K; Peacock, M ...
Published in: ENDOCRINE REVIEWS
June 1, 2014
Duke Scholars
Published In
ENDOCRINE REVIEWS
EISSN
1945-7189
ISSN
0163-769X
Publication Date
June 1, 2014
Volume
35
Issue
3
Publisher
ENDOCRINE SOC
Related Subject Headings
- Endocrinology & Metabolism
- 3215 Reproductive medicine
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 0601 Biochemistry and Cell Biology
Citation
APA
Chicago
ICMJE
MLA
NLM
Zhang, X., Imel, E. A., Ruppe, M. D., Weber, T. J., Klausner, M., Ito, T., … Carpenter, T. O. (2014). Pharmacokinetics (PK) and Pharmacodynamics (PD) Following Four Monthly Doses of a Human Monoclonal Anti-FGF23 (Fibroblast Growth Factor 23) Antibody (KRN23) in Adults with X-Linked Hypophosphatemia (XLH). In ENDOCRINE REVIEWS (Vol. 35). ENDOCRINE SOC.
Zhang, Xiaoping, Erik Allen Imel, Mary Denise Ruppe, Thomas Joseph Weber, Mark Klausner, Takahiro Ito, Maria Vergeire, et al. “Pharmacokinetics (PK) and Pharmacodynamics (PD) Following Four Monthly Doses of a Human Monoclonal Anti-FGF23 (Fibroblast Growth Factor 23) Antibody (KRN23) in Adults with X-Linked Hypophosphatemia (XLH).” In ENDOCRINE REVIEWS, Vol. 35. ENDOCRINE SOC, 2014.
Zhang X, Imel EA, Ruppe MD, Weber TJ, Klausner M, Ito T, et al. Pharmacokinetics (PK) and Pharmacodynamics (PD) Following Four Monthly Doses of a Human Monoclonal Anti-FGF23 (Fibroblast Growth Factor 23) Antibody (KRN23) in Adults with X-Linked Hypophosphatemia (XLH). In: ENDOCRINE REVIEWS. ENDOCRINE SOC; 2014.
Zhang, Xiaoping, et al. “Pharmacokinetics (PK) and Pharmacodynamics (PD) Following Four Monthly Doses of a Human Monoclonal Anti-FGF23 (Fibroblast Growth Factor 23) Antibody (KRN23) in Adults with X-Linked Hypophosphatemia (XLH).” ENDOCRINE REVIEWS, vol. 35, no. 3, ENDOCRINE SOC, 2014.
Zhang X, Imel EA, Ruppe MD, Weber TJ, Klausner M, Ito T, Vergeire M, Humphrey J, Glorieux FH, Portale AA, Insogna K, Peacock M, Carpenter TO. Pharmacokinetics (PK) and Pharmacodynamics (PD) Following Four Monthly Doses of a Human Monoclonal Anti-FGF23 (Fibroblast Growth Factor 23) Antibody (KRN23) in Adults with X-Linked Hypophosphatemia (XLH). ENDOCRINE REVIEWS. ENDOCRINE SOC; 2014.
Published In
ENDOCRINE REVIEWS
EISSN
1945-7189
ISSN
0163-769X
Publication Date
June 1, 2014
Volume
35
Issue
3
Publisher
ENDOCRINE SOC
Related Subject Headings
- Endocrinology & Metabolism
- 3215 Reproductive medicine
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 0601 Biochemistry and Cell Biology